Cargando…

Hepatic Necrosis after Trans-Arterial Embolization of Metastatic Neuroendocrine Tumour

Liver metastases from neuroendocrine tumours (NETs) are usually seen on cross-sectional imaging at presentation. In such cases, curative surgical resection is usually not possible given that most patients have bilobar disease. Various locoregional approaches are now widely available that enable loca...

Descripción completa

Detalles Bibliográficos
Autores principales: Micallef, Sarah, Cortis, Kelvin, Magri, Claude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213831/
https://www.ncbi.nlm.nih.gov/pubmed/32399442
http://dx.doi.org/10.12890/2020_001530
_version_ 1783531861792784384
author Micallef, Sarah
Cortis, Kelvin
Magri, Claude
author_facet Micallef, Sarah
Cortis, Kelvin
Magri, Claude
author_sort Micallef, Sarah
collection PubMed
description Liver metastases from neuroendocrine tumours (NETs) are usually seen on cross-sectional imaging at presentation. In such cases, curative surgical resection is usually not possible given that most patients have bilobar disease. Various locoregional approaches are now widely available that enable local control of disease and management of systemic symptoms. These include trans-arterial embolization (TAE), trans-arterial chemoembolization (TACE), selective internal radiotherapy and thermal ablation. We describe a rare case of hepatic necrosis after TAE in a 61-year-old woman with a metastatic NET. Cross-sectional imaging showed extensive necrosis affecting segments VII and VIII of the liver. This occurred secondary to thrombosis in the portal vein branches to these segments, confirmed on a Doppler ultrasound scan. The mechanism of portal vein thrombosis after TAE could be due to the presence of occult arterioportal anastomoses. These allow transit of the embolizing agents into the portal vein branches supplying the treated segments and subsequent thrombosis. LEARNING POINTS: Hepatic necrosis is a very rare but significant complication of TAE. The incidence of this complication after TAE has not yet been reported. Hepatic necrosis may be mimicked by the more commonly encountered post-embolization syndrome (PES). Hepatic necrosis should be suspected when symptoms are prolonged, or if the patient exhibits any form of deterioration. Prompt cross-sectional imaging is crucial in establishing diagnosis. Thorough supportive management is key in the setting of liver injury or failure. Sepsis should be treated aggressively with regular blood cultures and specialist input should be sought for optimization of antibiotic regimes.
format Online
Article
Text
id pubmed-7213831
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SMC Media Srl
record_format MEDLINE/PubMed
spelling pubmed-72138312020-05-12 Hepatic Necrosis after Trans-Arterial Embolization of Metastatic Neuroendocrine Tumour Micallef, Sarah Cortis, Kelvin Magri, Claude Eur J Case Rep Intern Med Articles Liver metastases from neuroendocrine tumours (NETs) are usually seen on cross-sectional imaging at presentation. In such cases, curative surgical resection is usually not possible given that most patients have bilobar disease. Various locoregional approaches are now widely available that enable local control of disease and management of systemic symptoms. These include trans-arterial embolization (TAE), trans-arterial chemoembolization (TACE), selective internal radiotherapy and thermal ablation. We describe a rare case of hepatic necrosis after TAE in a 61-year-old woman with a metastatic NET. Cross-sectional imaging showed extensive necrosis affecting segments VII and VIII of the liver. This occurred secondary to thrombosis in the portal vein branches to these segments, confirmed on a Doppler ultrasound scan. The mechanism of portal vein thrombosis after TAE could be due to the presence of occult arterioportal anastomoses. These allow transit of the embolizing agents into the portal vein branches supplying the treated segments and subsequent thrombosis. LEARNING POINTS: Hepatic necrosis is a very rare but significant complication of TAE. The incidence of this complication after TAE has not yet been reported. Hepatic necrosis may be mimicked by the more commonly encountered post-embolization syndrome (PES). Hepatic necrosis should be suspected when symptoms are prolonged, or if the patient exhibits any form of deterioration. Prompt cross-sectional imaging is crucial in establishing diagnosis. Thorough supportive management is key in the setting of liver injury or failure. Sepsis should be treated aggressively with regular blood cultures and specialist input should be sought for optimization of antibiotic regimes. SMC Media Srl 2020-03-19 /pmc/articles/PMC7213831/ /pubmed/32399442 http://dx.doi.org/10.12890/2020_001530 Text en © EFIM 2020 This article is licensed under a Commons Attribution Non-Commercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Articles
Micallef, Sarah
Cortis, Kelvin
Magri, Claude
Hepatic Necrosis after Trans-Arterial Embolization of Metastatic Neuroendocrine Tumour
title Hepatic Necrosis after Trans-Arterial Embolization of Metastatic Neuroendocrine Tumour
title_full Hepatic Necrosis after Trans-Arterial Embolization of Metastatic Neuroendocrine Tumour
title_fullStr Hepatic Necrosis after Trans-Arterial Embolization of Metastatic Neuroendocrine Tumour
title_full_unstemmed Hepatic Necrosis after Trans-Arterial Embolization of Metastatic Neuroendocrine Tumour
title_short Hepatic Necrosis after Trans-Arterial Embolization of Metastatic Neuroendocrine Tumour
title_sort hepatic necrosis after trans-arterial embolization of metastatic neuroendocrine tumour
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213831/
https://www.ncbi.nlm.nih.gov/pubmed/32399442
http://dx.doi.org/10.12890/2020_001530
work_keys_str_mv AT micallefsarah hepaticnecrosisaftertransarterialembolizationofmetastaticneuroendocrinetumour
AT cortiskelvin hepaticnecrosisaftertransarterialembolizationofmetastaticneuroendocrinetumour
AT magriclaude hepaticnecrosisaftertransarterialembolizationofmetastaticneuroendocrinetumour